LobbyingProfessional Compounding Centers of America lobbying by quarter
Professional Compounding Centers of America's latest lobbying report covers Q2 2026, at $230K. The four quarters Q4 2025–Q3 2026 total $610K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Pharmacy.
Professional Compounding Centers of America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $610K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $160K | 2 |
| Q1 2023 | $180K | 2 |
| Q2 2023 | $200K | 3 |
| Q3 2023 | $190K | 3 |
| Q4 2023 | $190K | 3 |
| Q1 2024 | $210K | 3 |
| Q2 2024 | $220K | 3 |
| Q3 2024 | $170K | 3 |
| Q4 2024 | $150K | 3 |
| Q1 2025 | $180K | 3 |
| Q2 2025 | $210K | 2 |
| Q3 2025 | $150K | 2 |
| Q4 2025 | $150K | 2 |
| Q1 2026 | $230K | 2 |
| Q2 2026 | $230K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$896.7K · 25 reports
- Pharmacy$896.7K · 25 reports
- Budget and appropriations$766.7K · 15 reports
- Health issues$260K · 23 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES38 reports
- SENATE38 reports
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseProfessional Compounding Centers of America | $2.3M | 15 quarters |
| Thorn Run Partners | $390K | 10 quarters |
| Hart Health Strategies | $130K | 13 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW VOGT | Senate HELP Committee | Q2 2026 |
| CLAIRE CASEY | Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22 | Q2 2026 |
| GARY PALMQUIST | Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen | Q1 2025 |
| JESSIE HOWE BRAIRTON | Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Hart Health Strategies | $10K |
| 07/20for Q2 | In-house | $220K |
| 04/20for Q1 | In-house | $220K |
| 04/20for Q1 | Hart Health Strategies | $10K |
| 01/20for Q4 2025 | In-house | $140K |
| 01/16for Q4 2025 | Hart Health Strategies | $10K |
| 25/10/20for Q3 2025 | Hart Health Strategies | $10K |
| 25/10/20for Q3 2025 | In-house | $140K |
| 25/07/21for Q2 2025 | In-house | $200K |
| 25/07/10for Q2 2025 | Hart Health Strategies | $10K |
| 25/04/21for Q1 2025 | In-house | $140K |
| 25/04/18for Q1 2025 | Hart Health Strategies | $10K |
| 25/04/17for Q1 2025 | Thorn Run Partners | $30K |
| 25/01/21for Q4 2024 | In-house | $100K |
| 25/01/19for Q4 2024 | Thorn Run Partners | $40K |
| 25/01/05for Q4 2024 | Hart Health Strategies | $10K |
| 24/10/21for Q3 2024 | In-house | $120K |
| 24/10/18for Q3 2024 | Thorn Run Partners | $40K |
| 24/10/10for Q3 2024 | Hart Health Strategies | $10K |
| 24/07/22for Q2 2024 | In-house | $170K |